Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Despite considerable epidemiological evidence indicating comorbidity between metabolic disorders, such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease, and inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, as well as common pathophysiological featu...
Main Author: | Chang-Kee Hyun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/17/9139 |
Similar Items
-
INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01) -
Inflammatory bowel disease in children
by: Maciej Putowski, et al.
Published: (2019-08-01) -
Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD
by: Amanda M Johnson, et al.
Published: (2021-01-01) -
Prevalence of inflammatory bowel disease in the Chelyabinsk Region
by: A. I. Dolgushina, et al.
Published: (2019-12-01) -
Whatever we should know about inflammatory bowel diseases
by: Asemi, S
Published: (1998-05-01)